Antimicrobial resistance in European medical schools contributes to enhancing education on antimicrobial resistance in medical schools in Europe. By increasing AMR awareness amongst future medical doctors, we can help curb inappropriate antimicrobial prescriptions, and reduce antimicrobial residues in the environment and exposures to AMR.
Based on interviews with 150 experts from the public health, policy and scientific communities, this report gives an update on the status quo, recent developments and remaining critical gaps in the AMR response globally.
European Antibiotic Awareness Day (EAAD) takes place on Wednesday 18 November 2020, in partnership with the World Health Organisation’s (WHO) World Antimicrobial Awareness Week (18 – 24 November 2020). EAAD is a European initiative that aims to raise awareness about the threat to public health of antibiotic resistance, and the importance of prudent antibiotic use. The latest available data confirms that across the European Union the number of patients infected by resistant bacteria is increasing and that antibiotic resistance is a major threat to public health.
Irish Government Events
18 – 24 November 2020
World Antimicrobial Awareness Week (WAAW) aims to increase awareness of global antimicrobial resistance (AMR) and to encourage best practices among the general public, health workers and policy makers to avoid the further emergence and spread of drug-resistant infections.
Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi, and parasites resist the effects of medications, making common infections harder to treat and increasing the risk of disease spread, severe illness and death. Antimicrobials are agents that are critical tools for fighting diseases in humans, animals and plants and include antibiotic, antiviral, antifungal and antiprotozoal medicines. Multiple factors – including overuse of medicines in humans, livestock, and agriculture, as well as poor access to clean water, sanitation and hygiene – have accelerated the threat of antimicrobial resistance worldwide.
Click Link: WAAW
Pfizer Healthcare Ireland in collaboration with RCSI and AMR Ireland
bring you a free-of-charge event
‘AMR: Can we change a resistant culture?’
on 19th November 2020, 19:00-21:00
Click link for Details and Registration: AMR Event
AMR Stakeholder Network (European Public Health Alliance)
Three online discussions in the run up to European Antibiotic Awareness Day hosted by the MEP Interest Group on AMR to raise awareness of the need for action, and find evidence-informed policy solutions to this urgent threat to human, animal and environmental health.
Take part in the debate and discuss what can can be done to boost actions to tackle AMR at EU level.
Webinar 1 – 13th November 2020: AMR in the Environment: From Monitoring to Action
Webinar 2 – 16th November 2020: Tackling the dependence of EU food systems on antimicrobials
Webinar 3 – 17th November 2020: Fixing the antibiotic innovation pipeline
Mileutis Ltd., a company based in Ness Ziona, Israel raised $20 million to develop a drug that is designed to treat mastitis in cows. The private venture capital company, U.S.-based NovaQuest Capital Management LLC, which specializes in health and life sciences and oversees some $2 billion in investments, invested in the Israeli company. NovaQuest’s investment is the first of its kind in the health and life sciences sector and the first for Mileutis
Click link: Mileutis
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance. This Plan is based on the U.S. Government’s 2014 National Strategy for CARB, and builds on the first National Action Plan released in 2015 by expanding evidence-based activities that have already been shown to reduce antibiotic resistance, such as optimizing the use of antibiotics in human and animal health settings.
This Plan continues to prioritize infection prevention and control to slow the spread of resistant infections and reduce the need for antibiotic use. To ensure that patients receive the right antibiotic care, the Plan supports innovative approaches to developing and deploying diagnostic tests and treatment strategies. A One Health approach, which recognizes the relationships between the health of humans, animals, plants, and the environment, is integrated throughout the Plan, with an expanded effort to understand antibiotic resistance in the environment. The Plan also focuses on collecting and using data to better understand where resistance is occurring, support the development of new diagnostics and treatment options, and advance international coordination.
Click link: Plan
The Minister for State in the Department of Agriculture, Food and the Marine, Senator Pippa Hackett, has launched the Code of Good Practice regarding the responsible use of antimicrobials in sheep.
Launching it, the Minister said ‘‘This Code of Good Practice will serve as a useful tool for sheep farmers as they work to address the ‘One Health’ challenge of Antimicrobial Resistance (AMR).”
The Minister welcomed the Code, as a means of highlighting the continued global concern in relation to AMR and its potential threat to human and animal health, as well as the challenges to food security and the environment. She commented, ‘‘Antibiotics need to be safeguarded for the benefit of both humans and animals, and strategies to reduce the use of antibiotics in both the human and animal health sectors is seen as a key intervention.”
Click link: Launch
In November 2019, MTPConnect convened a multi-disciplinary workshop to bring together key stakeholders from the health and medical research sector, the biotech and pharmaceutical industry, government and regulators to assess the challenges and see what could be achieved.
‘Fighting Superbugs: A Report on the Inaugural Meeting of Australia’s Antimicrobial Resistance Stakeholders’, prepared by MTPConnect in partnership with Biointelect, details those discussions and makes a series of recommendations for new and improved approaches to addressing drug resistance.
In September 2020, MTPConnect announced the formation of an Australian-first network bringing together key stakeholders to address the impact of antimicrobial resistance (AMR) on human health. The Australian Antimicrobial Resistance network – AAMRNet – has been established following recommendations made in this report.
Click link: AAMRNet report